The recommended dose of doxycycline for PEP is 200mg taken within 72 hours after sex. The Centers for Disease Control and Prevention (CDC) is recommending the use of doxycycline postexposure ...

This is the first human case of H5N2 known to infect a person. HealthDay News — A 59-year-old person in Mexico is the first human in the world known to be infected with the H5N2 strain of avian flu, ...

Dr Peter Marks urged the committee to consider encouraging the mRNA vaccine makers to focus on the latest versions of the virus, and not the JN.1 variant. HealthDay News — A US Food and Drug ...

Aneurysmal subarachnoid hemorrhage risk increased in association with current use of warfarin, venlafaxine, prochlorperazine, and co-codamol. HealthDay News — Several commonly prescribed drugs are ...

Prevalence of mpox 1.5% among emergency department patients evaluated for mpox-compatible rash. HealthDay News — Among emergency department patients evaluated for an mpox-compatible rash, the ...

Credit: Geron. The approval was based on data from the phase 2/3 IMerge study. The Food and Drug Administration (FDA) has approved Rytelo ™ (imetelstat) for the treatment of adult patients with low- ...

The FDA recommends patients with known sulfite allergies or sensitivities who receive compounded prescriptions ask compounders about the presence of sulfites in their products. Reports of ...

The FDA is reviewing the supplemental NDA for roflumilast cream 0.15%, a phosphodiesterase 4 inhibitor, for the treatment of atopic dermatitis. The sNDA is supported by data from the phase 3 ...

Results showed patients treated with ANX005 30mg/kg achieved a statistically significant 2.4-fold improvement on the GBS disability score at week 8 compared with placebo. Treatment with ANX005 was ...

Findings showed treatment with inebilizumab significantly reduced the risk of IgG4-RD flare by 87% compared with placebo. In patients with immunoglobulin G4-related disease (IgG4-RD), treatment with ...

The program automatically reduces the cost of the inhaler at the pharmacy for eligible patients with commercial insurance. Out-of-pocket costs for Boehringer Ingelheim asthma and chronic ...